1.5 EUR
0.04
2.74%
Last update Dec 16, 4:00 PM CET
Main market
Day range
1.44000
1.5
Previous close
1.46000
Open
1.44000
Access this stock data via API
Subscribe
Protalix Biotherapeutics Inc.
1.50
0.04
2.74%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 15.2M 13.3M 8.6M 15.5M
Cost of revenue 7.1M 5.0M 7.0M 3.3M
Gross profit 8.1M 8.3M 1.6M 12.2M
Operating expense
Research & development 3.8M 5.1M 3.0M 3.5M
Selling general and admin 2.5M 2.2M 2.2M 2.6M
Other operating expenses
Operating income 1.8M 998.8K -3.5M 6.1M
Non operating interest income
Income 245.4K 231.8K 357.1K 96.3K
Expense 153.4K 667.3K 5.1K 5.1K
Other income expense
Pretax income 1.9M 563.3K -3.2M 6.2M
Tax provision -98.9K 423.6K -96.3K 700.5K
Net income 2.0M 139.8K -3.1M 5.5M
Basic EPS 0.0 0 -0.1
Diluted EPS 0.0 0 -0.1
Basic average shares 67.6M 67.0M 65.3M
Diluted average shares 68.9M 69.3M 65.3M
EBITDA 2.4M 1.5M -2.9M 6.5M
Net income from continuing op. 2.0M 139.8K -3.1M 5.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 57 minutes

15:02
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).